ProShares UltraShort Nasdaq Biotechnology (BIS:NASDAQ) closed at $11.46 on October 23, 2026, up 2.41% on the day. The stock trades 50.1% below its 52-week high of $22.98 and 9.0% above its 52-week low of $10.51. Over the past year, it lost 1.2%. ProShares UltraShort Nasdaq Biotechnology is part of the Miscellaneous sector.
In 252 trading sessions since October 23, 2025, BIS closed higher on 114 days (45%). Its best day was December 1, 2025 (+109.58%) and its worst was August 19, 2026 (-12.76%). The stock moved 10% or more in a single session 2 times. It opened at least 5% above the previous day's high 1 time.
The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®. The fund invests in derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times the inverse (-2x) of the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. It is non-diversified.
Find more stocks like BIS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.